AC Immune (ACIU) Cash from Investing Activities (2015 - 2025)
AC Immune (ACIU) reported Cash from Investing Activities of $20.0 million for Q4 2025, up 558.45% year-over-year from $3.0 million in Q4 2024, and down 22.36% on a QoQ basis from $25.8 million in Q3 2025.
AC Immune (ACIU) has 11 years of Cash from Investing Activities data on file, last reported at $20.0 million in Q4 2025.
- Quarterly Cash from Investing Activities rose 558.45% year-over-year to $20.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $78.0 million (up 166.34% YoY) and the FY2025 annual result came in at $76.6 million, up 163.77% from the prior year.
- Cash from Investing Activities slipped to $20.0 million in Q4 2025 per ACIU's latest filing, from $25.8 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $46.3 million in Q1 2023 and bottomed at -$83.8 million in Q2 2024.
- The 5-year median for Cash from Investing Activities is -$561917.7 (2021), against an average of -$69004.6.
- The widest annual swing landed in 2023, when Cash from Investing Activities jumped 8013.88%; it then sank 1362.29% in 2024.
- Tracing ACIU's Cash from Investing Activities over 5 years: stood at -$23.6 million in 2021, then jumped by 121.85% to $5.1 million in 2022, then jumped by 409.85% to $26.2 million in 2023, then plunged by 116.64% to -$4.4 million in 2024, then jumped by 558.45% to $20.0 million in 2025.
- Per Business Quant, the three latest ACIU Cash from Investing Activities figures stand at $20.0 million (Q4 2025), $25.8 million (Q3 2025), and $28.8 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -428.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -25.54 Mn |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 20.02 Mn |
| Dec 31, 2025 | 20.02 Mn |
| Sep 30, 2025 | 25.79 Mn |
| Sep 30, 2025 | 25.79 Mn |
| Jun 30, 2025 | 28.85 Mn |
| Jun 30, 2025 | 28.85 Mn |
| Mar 31, 2025 | 3.37 Mn |
| Mar 31, 2025 | 3.37 Mn |
| Dec 31, 2024 | -4.37 Mn |
| Dec 31, 2024 | -4.37 Mn |
| Sep 30, 2024 | -2.41 Mn |
| Sep 30, 2024 | -2.41 Mn |
| Jun 30, 2024 | -83.84 Mn |
| Jun 30, 2024 | -83.84 Mn |
| Mar 31, 2024 | -26.99 Mn |
| Mar 31, 2024 | -26.99 Mn |
| Dec 31, 2023 | 26.24 Mn |
| Dec 31, 2023 | 26.24 Mn |
| Sep 30, 2023 | 5.34 Mn |
| Sep 30, 2023 | 5.34 Mn |
| Jun 30, 2023 | -5.73 Mn |
| Jun 30, 2023 | -5.73 Mn |
| Mar 31, 2023 | 46.27 Mn |
| Mar 31, 2023 | 46.27 Mn |
| Dec 31, 2022 | 5.15 Mn |
| Dec 31, 2022 | 5.15 Mn |
| Sep 30, 2022 | -5.30 Mn |
| Sep 30, 2022 | -5.30 Mn |
| Jun 30, 2022 | 25.40 Mn |
| Jun 30, 2022 | 25.40 Mn |
| Mar 31, 2022 | -584,716.52 |
| Mar 31, 2022 | -584,716.52 |
| Dec 31, 2021 | -23.56 Mn |
| Dec 31, 2021 | -23.56 Mn |
| Sep 30, 2021 | -539,118.91 |
| Sep 30, 2021 | -539,118.91 |
| Jun 30, 2021 | -33.62 Mn |
| Jun 30, 2021 | -33.62 Mn |
| Mar 31, 2021 | -873,786.66 |
| Mar 31, 2021 | -873,786.66 |
| Dec 31, 2020 | 4.61 Mn |
| Dec 31, 2020 | 4.61 Mn |
| Sep 30, 2020 | 16.02 Mn |
| Sep 30, 2020 | 16.02 Mn |
| Jun 30, 2020 | 9.99 Mn |
| Jun 30, 2020 | 9.99 Mn |
| Mar 31, 2020 | -219,175.48 |
| Mar 31, 2020 | -219,175.48 |
| Dec 31, 2019 | -5.64 Mn |
| Dec 31, 2019 | -5.64 Mn |
| Sep 30, 2019 | -10.61 Mn |
| Sep 30, 2019 | -10.61 Mn |
| Jun 30, 2019 | -338,087.38 |
| Jun 30, 2019 | -338,087.38 |
| Mar 31, 2019 | -50.72 Mn |
| Mar 31, 2019 | -50.72 Mn |
| Dec 31, 2018 | -30.47 Mn |
| Dec 31, 2018 | -30.47 Mn |
| Sep 30, 2018 | -141,278.09 |
| Sep 30, 2018 | -141,278.09 |
| Jun 30, 2018 | -416,541.53 |
| Jun 30, 2018 | -416,541.53 |
| Mar 31, 2018 | -1.22 Mn |
| Mar 31, 2018 | -1.22 Mn |
| Dec 31, 2017 | 1.86 Bn |
| Dec 31, 2017 | 1.86 Bn |
| Sep 30, 2017 | -1.91 Bn |
| Sep 30, 2017 | -1.91 Bn |
| Jun 30, 2017 | -936,843.80 |
| Jun 30, 2017 | -936,843.80 |
| Mar 31, 2017 | -638,412.59 |
| Mar 31, 2017 | -638,412.59 |
| Dec 31, 2016 | -286,006.99 |
| Dec 31, 2016 | -286,006.99 |
| Sep 30, 2016 | -313,686.90 |
| Sep 30, 2016 | -313,686.90 |
| Jun 30, 2016 | -99,971.90 |
| Jun 30, 2016 | -99,971.90 |
| Mar 31, 2016 | -211,452.72 |
| Mar 31, 2016 | -211,452.72 |
| Dec 31, 2015 | -5,052.66 |
| Dec 31, 2015 | -5,052.66 |